Log in to save to my catalogue

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients unde...

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients unde...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_470111

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

About this item

Full title

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3068-3077

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cytogenetic and molecular abnormalities are known to influence post-transplant outcomes in acute myeloid leukemia (AML) but data assessing the prognostic value of combined genetic models in the HCT setting are limited. We developed an adapted European LeukemiaNet (aELN) risk classification based on available genetic data reported to the Center for...

Alternative Titles

Full title

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_470111

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_470111

Other Identifiers

ISSN

0268-3369,1476-5365

E-ISSN

1476-5365

DOI

10.1038/s41409-021-01450-3

How to access this item